Cancer Defense &
Family Vigilance
Hereditary risk, early molecular signals, and lifestyle-driven inflammation accumulate silently. Standard health screens are not designed to find them.
Most cancers are preceded by detectable signals. Most are never looked for.
Hereditary risk, early molecular signals, and lifestyle-driven inflammation accumulate silently. Standard annual health screens are not designed to find them. The Vivere Cancer Defense protocol combines hereditary genetic assessment, multi-cancer early detection, and evidence-based chemoprevention — calibrated for Singapore’s cancer epidemiology.
For women with a family history of cancer, or those seeking the most comprehensive prevention available, this protocol closes the gap between what standard medicine offers and what precision medicine can now detect — while there is still time to act.
Hallmarks of Aging at the Foundation of Cancer Risk
Cancer risk is rooted in genomic instability, epigenetic dysregulation, cellular senescence, and chronic inflammation — each of which this protocol directly targets through detection and modifiable intervention.
López-Otín et al., Cell 2023. Highlighted hallmarks reflect primary mechanistic targets of this protocol.
Your Cancer Defense Biomarker Panel
Seven investigation sets spanning hereditary risk, molecular early detection, structural imaging, and modifiable inflammatory and metabolic drivers — each selected for clinical actionability.
From Hereditary Risk Assessment to Prevention Plan
A structured six-step programme that integrates hereditary risk, molecular early detection, and modifiable cancer risk factors into a single, personalised surveillance and prevention strategy.
Knowing your hereditary risk changes your surveillance schedule, your prevention options, and in some cases, the clinical decisions available to you.
Hereditary Risk
Up to 10% of breast cancers and 15% of ovarian cancers are caused by inherited gene variants. Most carriers do not know.
Early Detection
Multi-cancer early detection technology can identify molecular signals years before symptoms or imaging findings appear.
Hereditary Risk Consultation
Physician-led family history assessment and personalised cancer risk profiling.
Genetic Risk Assessment
Clinically indicated blood-based evaluation of hereditary cancer susceptibility, reviewed alongside your family history.
Molecular Cancer Surveillance
Advanced molecular screening for early cancer signals using a single blood draw, where clinically indicated.
Structural Imaging Assessment
Personalised structural imaging interpreted alongside your genetic and biomarker results, guided by your individual risk profile.
Inflammatory & Metabolic Panel
Inflammation and metabolic risk markers that modify cancer susceptibility.
Risk Review & Prevention Plan
Your physician presents your integrated hereditary and modifiable cancer risk — with a personalised surveillance and chemoprevention strategy.
Every result is reviewed in a physician-led consultation. Your protocol is built on your data, not a template.
Book a Consultation